Drugs for Diabetes Mellitus + Endocrine + Gonadal Hormone + Thyroid Flashcards
Parentral hypoglycemic agent/Insulin/Insulin analogues /Insulin preparation
- Rapid acting/Ultra short acting
- Short actng
- Intermediate acting
- Long acting/Insulin analogues
page-474
AntiDiabetic drugs name ?
- Parental hypoglycemic agnets -INSULIN
- Oral H A - CHART
PAGE-474
Insulin analogous name ?
Rapid acting/Ultra short acting
1. I LISPRO
2. I ASPART
3. Human I recombinant inhaled
Short acting insulin
1. Regular-Natural-Soluble Insulin
Intermediate acting insulin
1.Isophane insulin
2.I Zn suspension
Long acting insulin
1.Protamine Zn I suspension
2.I glargine
3.I detemir
Bolus Insulin ?
short/rapid acting insulin that is given before meal to control post meal rise of blood sugar
476
Basal insulin ?
long acting insulin that is released slowly over a period of between 8-24 hours intemded to supply the basal level of insulin during the day and particularly at night time
page-476
Indications of insulin ?
- type-1 dm
- uncontrolled dm-ii
- dm in = 🤰 =RTA = severe infection = post operative patient
- d ketoacidosis
- d nephropathy
- d neuropathy
- d retinopathy
- hyperkalemia
477
A/E of insulin ?
- insulin hypersensitivity
- insulin resresistance
- insulin edema
- hypokalemia
- hypoglycemia
- obesity
- alopecia
- inc cancer risk
page 477
Hypoglycemia-Clinical features ?
- tachycardia
- palpitations
- severe sweating
- nausea
- hunger
- convulsion
- coma
- dealth
478
Tx of Hypoglycemia ?
- Mild H in a patient who can swallow
simple sugar/glucose in liquid form
Glucose gel,honey,sweet,dextrose tablet
2.Unconscious patient
Inj Glucagon(1mg) - (S/C - IM)
Inj 3mg- intranal restore
50% glucose solution IV infusion
page-478
Oral hypoglycemic agents ?
Insulin secretagogues
1.SulfonylUreas
1st Generation
-Tolbutamide
-TolAzamide
2nd Generation
-Glipizide
-Gliclazide
-glimepiride
2.Meglitinides=Repaglinide
Insulin sensitizers
Biguanide = Metformin
ThiazolidineDiones= PIO & ROSI glitazone
Mechanism of SulfonylUreas?
=Block ATP Sensitive K channel
=dec outward K efflux
=depolarization of B cell
=opening of voltage gated Ca channel
=inc intracellular Ca
=inc secretion of Insulin
page-483
Indication of SulfonylUreas?
- DM-II
- Combination of DM-I & DM-II
A/E of SulfonylUreas?
- Hypoglycemia
- Weight gain
- nausea
- vomiting
- Teratogenecity
- Aplastic anemia
- Hemolytic anemia
page-484
Contraindiaction ??
- 🤰
- Lactation
- Renal insufficiency
- Hepatic insufficiency
- Type-1 DM
Metformin Mechanism ??
=inc Glucose——-Lactose
=inc glycolysis
=inc glucose removal
=dec plasma glucagon
=dec hepatic & renal gluconeogenesis
=dec glucose absorption
Metfromin indication ?
- DM-2
- Insulin resistance syndrome
- Type-2 DM in obese persons
A/E of Metformin ?
- Anorexia
- nausea
- vomiting;diarrhea
- lactic acidosis
- acute kidney failure
- dec V-B12 absorption
- megaloblastic anemia
486
ThiazoLidineDione mechanism ?
- ThiazoLidineDione binds with PPAR-GAMA in muscle fat liver
- express the gene involve in lipid and glucose metabolism ,insulin signal transduction
- promotes glucose uptakle and utilization
487
Dipeptidyl peptidase IV Inhibitors name ?
GLIPTIN
sita-saxa-lina-alo-vilda
489
SitaGliptin Mechanism ?
=inhibit DPP-IV
=dec GLP-1 GIP
=degrade GLP-1 LIKE MOLECULES
=degrade incretin
=inc GLP-1 GIP
=dec postprandial glucose excursions
=inc glucose mediated insulin secretion
=dec glucagon level
489
SGLT-2 Inhibitors Name ?
GLIFLOZIN
empa-cana-dapa-ertu
491
SGLT-2 INHIBITORS mechanism ?
=G freely filtered by renal glomeruli
=reabsorbed in PCT
=Action of SGLT-2
=Causes-Glycosuria & Lower glucose level in DM-2 patient
page-491
which Genration of sulfonylurease is better ?
2nd
why 2nd one better ?
Higher potency: They are effective at much lower doses.
Improved safety profile: Lower risk of drug interactions and side effects. Longer duration of action: Allow for once- or twice-daily dosing, improving patient compliance. Reduced hypoglycemia risk: Compared to first-generation agents, though still a concern.